BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25438965)

  • 1. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
    Chao C; Preciado M; Slezak J; Xu L
    J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion.
    Patel A; Stern L; Unger Z; Debevec E; Roston A; Hanover R; Morfesis J
    Vaccine; 2014 May; 32(21):2428-33. PubMed ID: 24631099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
    Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009.
    Dorell CG; Stokley S; Yankey D; Markowitz LE
    Vaccine; 2012 Jan; 30(3):503-5. PubMed ID: 22119587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting completion of the human papillomavirus vaccine series.
    Gold R; Naleway A; Riedlinger K
    J Adolesc Health; 2013 Apr; 52(4):427-32. PubMed ID: 23298984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.
    McLean HQ; VanWormer JJ; Chow BDW; Birchmeier B; Vickers E; DeVries E; Meyer J; Moore J; McNeil MM; Stokley S; Gee J; Belongia EA
    J Adolesc Health; 2017 Aug; 61(2):252-258. PubMed ID: 28462786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
    Liu G; Kong L; Du P
    Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance and compliance with postpartum human papillomavirus vaccination.
    Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
    Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents.
    Rand CM; Brill H; Albertin C; Humiston SG; Schaffer S; Shone LP; Blumkin AK; Szilagyi PG
    J Adolesc Health; 2015 May; 56(5 Suppl):S17-20. PubMed ID: 25863549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based reminder intervention to improve human papillomavirus vaccination rates among adolescents at routine vaccination age.
    Coley S; Hoefer D; Rausch-Phung E
    Vaccine; 2018 Aug; 36(32 Pt B):4904-4909. PubMed ID: 30037480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HPV vaccine: are dosing recommendations being followed?
    Tan W; Viera AJ; Rowe-West B; Grimshaw A; Quinn B; Walter EB
    Vaccine; 2011 Mar; 29(14):2548-54. PubMed ID: 21300098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.
    Perkins RB; Chigurupati NL; Apte G; Vercruysse J; Wall-Haas C; Rosenquist A; Lee L; Clark JA; Pierre-Joseph N
    Hum Vaccin Immunother; 2016 Jun; 12(6):1528-35. PubMed ID: 26810765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental Choice of Recall Method for HPV Vaccination: A Pragmatic Trial.
    Kempe A; O'Leary ST; Shoup JA; Stokley S; Lockhart S; Furniss A; Dickinson LM; Barnard J; Daley MF
    Pediatrics; 2016 Mar; 137(3):e20152857. PubMed ID: 26921286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.
    Harper DM; Verdenius I; Harris GD; Barnett AL; Rosemergey BE; Arey AM; Wall J; Malnar GJ
    Prev Med; 2014 Apr; 61():20-5. PubMed ID: 24440159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of the human papillomavirus vaccine: a review of the literature and report of a quality assurance project.
    Cassidy B; Schlenk EA
    J Pediatr Health Care; 2012 Mar; 26(2):92-101. PubMed ID: 22360928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students.
    Richman AR; Maddy L; Torres E; Goldberg EJ
    J Am Coll Health; 2016; 64(4):269-78. PubMed ID: 26821923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing HPV vaccination series completion rates via text message reminders.
    Matheson EC; Derouin A; Gagliano M; Thompson JA; Blood-Siegfried J
    J Pediatr Health Care; 2014; 28(4):e35-9. PubMed ID: 24200295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.
    Rahman M; Laz TH; McGrath CJ; Berenson AB
    Clin Pediatr (Phila); 2015 Dec; 54(14):1328-33. PubMed ID: 25848128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
    Cook RL; Zhang J; Mullins J; Kauf T; Brumback B; Steingraber H; Mallison C
    J Adolesc Health; 2010 Dec; 47(6):596-9. PubMed ID: 21094437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
    Richards MJ; Peters M; Sheeder J
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.